Hannah Green is a reporter with a focus on local news in the Charlotte, North Carolina area. She has written for various publications including the Charlotte Business Journal, New England Cable News, and iRunFar.com. Hannah's work covers a range of topics including business, sports, and social issues.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Charlotte, North Carolina, United States (Local)
Hannah Green's focus seems to be on local news, particularly in the Boston area. Her coverage includes press releases and private sector announcements related to software & SaaS, business & industry, government & politics with topics such as innovation, startups, venture capital and leadership.
For effective pitching to Hannah Green, consider providing newsworthy stories about local businesses in Boston or surrounding areas that are related to software development and startups. Additionally, she may be interested in exclusive interviews or insights from leaders within these industries. Keep in mind her strong focus on the Boston area when crafting your pitches.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Hannah Green, Kristoffer Paulsen
The Brunswick East eatery enters a new era with a new chef as Rosheen Kaul steps away from the pans to spend more time writing.
By: Hannah Green
BBJ Scoop: A new Cambridge startup, Skylark Bio, which is aiming to treat pediatric genetic hearing loss, has gotten a $40 million Series A investment.
First sickle cell patient begins bluebird gene therapy treatment
Flagship commits $50M to spinout using viral proteins, machine learning
'This isn’t just real estate. It’s about patients': Bob Coughlin talks new JLL role
Study shows potential disparities in early access to Biogen, Eisai's Alzheimer's drug
Local obesity drug developer lands deal worth up to $600M with Novo Nordisk
By: Hannah Green
Takeda, Massachusetts' largest life science employer, said on Thursday that it plans to kick off a “significant, multi-year efficiency program” as it enters its 2024 fiscal year.
By: Hannah Green
Here's how much the 10 highest-paid CEOs of Massachusetts-based, publicly traded life science companies reported in total compensation last year.
Cambridge-NYC biotech gets $95M, prepares to enter clinic with blood cancer drug
(833) 317-6278 
